Developing advanced techniques for synthesizing and analyzing new drugs
Official title: Acquisition of a Supercritical Fluid Chromatography Mass Spectrometer System
Funded at University of Wisconsin-Madison · NIH-10852553 · Data updated 2026-11-12
This study is all about getting a new high-tech machine to help scientists at the University of Wisconsin-Madison create and understand new medicines better, which could lead to more effective treatments for various health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $287,665 |
| NIH project number | 1S10OD036302-01 |
| Project ID | NIH-10852553 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceuticals developed through these advanced synthesis techniques.
✕Less likely to help
Patients with conditions that are not addressed by the specific drugs being developed in this research may not receive any benefit.
What this research studies
This research focuses on acquiring a state-of-the-art chromatography mass spectrometer system to enhance the characterization of novel molecules synthesized at the University of Wisconsin-Madison. The system will support various projects aimed at addressing critical biological questions and challenges in drug synthesis. Researchers will utilize advanced techniques to develop new strategies for creating complex organic molecules and small-molecule therapeutics, which could lead to more effective medications. The work involves collaboration among multiple research groups, each contributing unique methodologies to improve drug discovery and development.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and affordable medications for patients.
How similar studies have gone: Other research has shown success with similar advanced drug synthesis techniques, indicating a promising potential for breakthroughs in pharmaceutical development.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Heins, Spencer — University of Wisconsin-Madison
- Study coordinator: Heins, Spencer
Related research
Other NIH-funded projects on the same topics.
-
BRAVE Innovation Center for Viral Resistance in Chickens
A center at UW–Madison aims to create chickens genetically resistant to avian viruses like H5N1 by identifying host genes involved in virus replication using genome-wide CRISPR screening.
-
Center to Fight Vector-Borne Diseases in the Midwest
A Midwest program brings researchers, public health teams, and vector-control groups together to prevent diseases spread by ticks and mosquitoes.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Neutrophil development with stem cells to understand their behavior
Researchers are studying how neutrophils, a type of immune cell, develop from stem cells to better understand why they can help or harm in infections and inflammatory diseases.
-
WREN: Expanding Research Capacity in Rural Primary Care Clinics
A nationwide network in Wisconsin will strengthen rural primary care clinics to participate in real-world research and bring more clinical trials to communities.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.